论文部分内容阅读
目的:研究生长抑素治疗肠梗阻的临床治疗效果。方法:选择2013年1月至2015年1月我院收治的60例肠梗阻患者作为研究对象,根据不同治疗方法,把60例患者随机均分为两组,每组各30例。一组为对照组给予常规治疗,另一组为观察组在常规治疗同时给予生长抑素治疗,对比两组患者的临床治疗效果。结果:观察组临床治疗总有效率90%,对照组治疗总有效率50%,观察组治疗总有效率明显高于对照组;经过5d治疗后,对比两组患者排气率、排便率、腹痛腹胀改善率等,观察组明显优于对照组,两组对比差异明显,具有统计学意义(P<0.05)。结论:生长抑素可以提高患者临床的排气率、排便率,有效改善患者腹胀腹痛症状,临床治疗效果较为理想,建议临床推广应用。
Objective: To study the clinical effect of somatostatin on intestinal obstruction. METHODS: Sixty patients with intestinal obstruction admitted to our hospital from January 2013 to January 2015 were selected as study subjects. According to the different treatment methods, 60 patients were randomly divided into two groups of 30 patients in each group. One group was given routine treatment in the control group, and the other group was given the somatostatin treatment at the same time as the conventional treatment in the observation group. The clinical treatment effect was compared between the two groups. Results: The total effective rate was 90% in the observation group and 50% in the control group. The total effective rate in the observation group was significantly higher than that in the control group. After 5 days of treatment, the rates of exhaust, defecation, abdominal pain Abdominal distension improvement rate, the observation group was significantly better than the control group, significant difference between the two groups, with statistical significance (P <0.05). Conclusion: Somatostatin can improve clinical patients’ clinical rate of excretion and defecation and effectively improve the symptoms of abdominal distension and abdominal pain. The clinical effect is ideal and it is recommended for clinical application.